Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 20 853 27 390 30 578 31 851 33 940 36 375
EBITDA 5 525 7 022 9 833 8 269 9 141 10 057
Operating profit (EBIT) 4 172 5 976 6 555 7 153 7 895 8 666
Pre-Tax Profit (EBT) 1 413 2 231 2 873 3 920 4 661 -
Net income 1 063 353 2 334 3 655 4 487 5 735
P/E ratio 54,1x 285x 55,2x 40,8x 33,8x 28,3x
EPS ( $ ) 0,71 0,20 1,31 2,10 2,53 3,03
Dividend per Share ( $ ) 1,05 1,08 1,16 1,26 1,36 1,47
Yield 2,72% 1,88% 1,60% 1,48% 1,59% 1,72%
Reference price ( $ ) 38,410 57,070 72,330 85,480 85,480 85,480
Announcement Date 01/25/2017
12:45pm
01/24/2018
12:45pm
01/23/2019
12:45pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt 3 231 18 314 15 480 13 029 5 641 8 094
Finance - - - - - -
Operating income (EBITDA) 5 525 7 022 9 833 8 269 9 141 10 057
Leverage
(Debt/EBITDA)
0,58x 2,61x 1,57x 1,58x 0,62x 0,80x
Capital Expenditure 1 121 1 000 1 394 1 593 1 646 1 731
Free Cash Flow (FCF) 2 082 4 435 4 906 5 638 6 451 7 195
Book Value Per Share (BVPS) ( $ ) 13,9 17,7 17,4 18,6 25,2 26,9
Cash Flow per Share ( $ ) 2,16 3,18 3,56 3,21 4,66 4,87
Announcement Date 01/25/2017
12:45pm
01/24/2018
12:45pm
01/23/2019
12:45pm
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 150 743 M $ -
Entreprise Value (EV) 163 772 M $ 156 384 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 40,8x 33,8x
Capitalization / Revenue 4,73x 4,44x
EV / Revenue 5,14x 4,83x
EV / EBITDA 19,8x 17,9x
Yield (DPS / Price) 1,48% 1,59%
Price to book (Price / BVPS) 4,59x 3,39x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 22,5% 23,3%
Operating Leverage (Delta EBIT / Delta Sales) 2,19x 1,58x
Net Margin (Net Profit / Revenue) 11,5% 13,2%
ROA (Net Profit / Asset) 6,90% 7,99%
ROE (Net Profit / Equities) 15,9% 15,6%
Rate of Dividend 60,4% 53,8%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   5,00% 4,85%
Cash Flow / Sales 17,8% 24,3%
Capital Intensity (Assets / Sales) 1,66x 1,65x
Financial Leverage (Net Debt / EBITDA) 1,58x 0,62x
EPS & Dividend